Home > > > > > Report Detail

Global Pulmonary Arterial Hypertension (PAH) Market: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 06-Aug-2018
No. of pages: 95
Inquire Before Buying

Pulmonary arterial hypertension (PAH) is one form of pulmonary hypertension (PH) condition, which means high blood pressure in the lungs. Many diseases such as obstructive sleep apnea (OSA), lung diseases, diastolic heart failure and diseases of the left heart can cause the pressures in the pulmonary arteries to elevate but is not pulmonary arterial hypertension. PAH is a life threatening disease characterized by an increase in pulmonary vascular resistance that eventually leads to death. It is a rare disease, affects about 15-70 people per million in the U.S. The symptoms of PAH are difficult to diagnose as the symptoms are common to other diseases.

Pulmonary arterial hypertension is a severe condition and there is no cure to PAH at present time. Many treatments are available to improve symptoms, quality of life and to keep the condition under control. There are currently four classes of drugs approved for the treatment of PAH and 13 approved products are available for PAH in the market across these four drug classes.

The United States is the main contributor to the PAH market with the development of new therapies and increasing cases of pulmonary arterial hypertension. The U.S. has great potential in the years ahead with rising awareness about treatment options of PAH.

The global PAH market is expected to grow in the future due to increasing ageing population, rise in healthcare expenditure, growing women population, increase in obese population and high unmet needs. Key trends of this market include increasing number of cardiovascular diseases, rising government support, and consumption of junk food. However, there are some factors which can hinder the growth of the market which includes patent expiration, high cost and lack of awareness.

The report “Global Pulmonary Arterial Hypertension Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering The United States and Europe region along with the global market. The report profiles the key players in the market including Johnson & Johnson, Gilead Sciences, United Therapeutics and Glaxo SmithKline.

Global Pulmonary Arterial Hypertension (PAH) Market: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. Market Overview
1.1 Pulmonary Arterial Hypertension
1.2 Types of PAH
1.3 Causes and Risk Factors of PAH
1.4 Symptoms
1.5 Diagnosis
1.6 PAH Patient Grouping As Per WHO
1.7 Treatment
1.8 PAH Drugs Classification
1.9 Approved PAH Drugs
1.10 PAH Drugs In Development

2. Global Market Analysis
2.1 Global PAH Market by Value
2.2 Global PAH Market Forecast by Value
2.3 Global PAH Market by Drug Type
2.4 Global ERAs Drugs Market
2.4.1 Global ERAs Drugs Forecast Market by Value
2.4.2 Global Tracleer Revenue
2.4.3 Global Letairis Revenue
2.4.4 Global Opsumit Revenue
2.5 Global Prostacyclin Drugs Market
2.5.1 Global Prostacyclin Drugs Market Forecast by Value
2.5.2 Global Tyvaso Revenue
2.5.3 Global Remodulin Revenue
2.5.4 Global Veletri Revenue
2.5.5 Global Orentiram Revenue
2.6 Global PDE Drugs Market
2.6.1 Global PDE Drugs Market Forecast by Value
2.6.2 Global Revatio Revenue
2.6.3 Global Adrcica Revenue
2.7 Global sGC/Adempas Drugs Market
2.7.1 Global sGC Drugs Market Forecast by Value
2.8 Global Ralinepag Drug Revenue

3. Regional Market
3.1 The U.S.
3.1.1 The U.S. PAH Population Forecast
3.1.2 The U.S. PAH Incident Population Forecast
3.1.3 The U.S. PAH Population by WHO Patient Class Division
3.1.4 The U.S. WHO FC Patient Class Forecast
3.1.5 The U.S. Ralinepag Revenue
3.1.6 The U.S. Ralinepag Treated Patients
3.2 Europe
3.2.1 Europe PAH Population Forecast
3.2.2 Europe PAH Incident Population Forecast
3.2.3 Europe PAH Population by WHO Patient Class Division
3.2.4 Europe WHO FC Patient Class Forecast
3.2.5 Europe Ralinepag Revenue
3.2.6 Europe Ralinepag Treated Patients

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Healthcare Spending
4.1.2 Rising Ageing Population
4.1.3 Accelerating Economic Growth
4.1.4 Growing Female Population
4.1.5 Increase in Obese Population
4.1.6 Unmet Medical Needs
4.2 Trend & Developments
4.2.1 Growing Number of Cardiac Diseases
4.2.2 Growing Consumption of Fast Food
4.2.3 Favorable Government Support
4.3 Challenges
4.3.1 High Costs of Diagnosis and Treatment
4.3.2 Lack of Awareness
4.3.3 Expiry of Patents

5. Competitive Landscape
5.1 Global Market
5.1.1 Revenue and Market Cap Comparison
5.1.2 Research and Development Expenditure Comparison

6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 United Therapeutics Corporation
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 GlaxoSmithKline Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Gilead Sciences
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Tables

WHO Functional Classification Of Pulmonary Hypertension
Approved Drugs to Treat PAH
Drugs in Clinical Development for PAH
Key Players - Revenue & Market Cap Comparison (2017)
Key Players - Research and Development Expenditure Comparison (2017)
Annual Drugs Cost For PAH Treatment (2017)

List of Figures

Progression of PAH
Types of PAH
Global PAH Market by Value (2013-2017)
Global PAH Market Forecast by Value (2018-2022)
Global PAH Market by Drug Type (2017)
Global ERAs Drugs Market by Value (2013-2017)
Global ERAs Drugs Forecast Market by Value (2018-2022)
Global Tracleer Revenue (2013-2017)
Global Letairis Revenue (2013-2017)
Global Opsumit Revenue (2013-2017)
Global Prostacyclin Drugs Market by Value (2013-2017)
Global Prostacyclin Drugs Market Forecast by Value (2018-2022)
Global Tyvaso Revenue (2013-2017)
Global Remodulin Revenue (2013-2017)
Global Veletri Revenue (2013-2017)
Global Orentiram Revenue (2013-2017)
Global PDE Drugs Market by Value (2013-2017)
Global PDE Drugs Market Forecast by Value (2018-2022)
Global Revatio Revenue (2013-2017)
Global Adrcica Revenue (2013-2017)
Global sGC/Adempas Drugs Market by Value (2014-2017)
Global sGC Drugs Market Forecast (2018-2022)
Global Ralinepag Drug Revenue Forecast (2022-2025)
The U.S. PAH Population Forecast (2021-2025)
The U.S. PAH Incident Population Forecast (2021-2025)
The U.S. PAH Population by WHO Patient Class Division (2021)
The U.S. WHO FC Patient Class Forecast (2021-2025)
The U.S. Ralinepag Revenue (2022-2025)
The U.S. Ralinepag Treated Patients (2022-2025)
Europe PAH Population Forecast (2021-2025)
Europe PAH Incident Population Forecast (2021-2025)
Europe PAH Population by WHO Patient Class Division (2021)
Europe WHO FC Patient Class Forecast (2021-2025)
Europe Ralinepag Revenue (2022-2025)
Europe Ralinepag Treated Patients (2022-2025)
Global Healthcare Spending Per Capita (2013-2017)
Global Ageing Population (2013-2017)
Global GDP Per Capita (2013-2017)
Global Female Population (2013-2017)
Global Obese Population (2013-2017)
Cardiovascular Deaths in the U.S. (2017)
Johnson & Johnson Sales by Segments (2017)
Johnson & Johnson Sales and Net Earnings (2013-2017)
Johnson & Johnson R&D Expenditure (2015-2017)
United Therapeutics Revenue by Product (2017)
United Therapeutics Revenue and Net Income (2013-2017)
United Therapeutics R&D Expenditure (2015-2017)
GlaxoSmithKline Turnover by Segment (2017)
GlaxoSmithKline Turnover and Profit (2013-2017)
GlaxoSmithKline R&D Expenditure (2015-2017)
Gilead Sciences Revenue by Geographical Region (2017)
Gilead Sciences Revenue and Net Income (2013-2017)
Gilead Sciences R&D Expenditure (2015-2017)

  • Global Idiopathic Pulmonary Fibrosis Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 83
    The global Idiopathic Pulmonary Fibrosis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is es......
  • Idiopathic Pulmonary Fibrosis Drug - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 93
    The global Idiopathic Pulmonary Fibrosis Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Idiopathic Pulmonary Fibrosis Drug in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Idiopathic Pulmonary Fibrosis Drug market. Glucocorticoid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ milli......
  • Global Idiopathic Pulmonary Fibrosis Drug Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 159
    Idiopathic pulmonary fibrosis (IPF) is scarring or thickening of the lungs without a known cause. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital......
  • Global Idiopathic Pulmonary Fibrosis Drug Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Idiopathic pulmonary fibrosis (IPF) is scarring or thickening of the lungs without a known cause. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital......
  • Global Idiopathic Pulmonary Fibrosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Idiopathic Pulmonary Fibrosis Drug market: According to our latest research, the global Idiopathic Pulmonary Fibrosis Drug market looks promising in the next 5 years. As of 2022, the global Idiopathic Pulmonary Fibrosis Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and compre......
  • Global Pirfenidone Market Research Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Pirfenidone is used for the treatment of idiopathic pulmonary fibrosis (scarring of the lungs with an unknown cause). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches......
  • Global Pirfenidone Professional Survey Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 109
    Pirfenidone is used for the treatment of idiopathic pulmonary fibrosis (scarring of the lungs with an unknown cause). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches......
  • Global Pirfenidone Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 03-Oct-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Pirfenidone market: According to our latest research, the global Pirfenidone market looks promising in the next 5 years. As of 2022, the global Pirfenidone market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Pirfenidone market, with a systematica......
  • Global Idiopathic Pulmonary Fibrosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Sep-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Idiopathic Pulmonary Fibrosis market: According to our latest research, the global Idiopathic Pulmonary Fibrosis market looks promising in the next 5 years. As of 2022, the global Idiopathic Pulmonary Fibrosis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs